On ECHEMI
Home > Drugs > Retinal periphlebitis
Retinal periphlebitis
This disease (retinal periphlebitis) is also called recurrent retinal vitreous hemorrhage in young people. Henry Eales first explained the relationship between vitreous hemorrhage and retinal veins in 1882 and reported it in detail, so it is also called Eales disease. It is more common in men aged 20 to 30. It often occurs in both eyes one after another within one year. It is easy to relapse.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    Male young adults aged 20 to 40
  • Related symptoms:

    Retinal hemorrhage Retinal edema Retinal detachment Retinal Roth spots
  • Concurrent disease:

Related Drugs
Dipyridamole
Indication: This product was once a commonly used drug for the treatment of coronary heart disease, but is now rarely used to prevent myocardial ischemia. Its antiplatelet aggregation effect can be used in heart surgery or valve replacement surgery to reduce the formation of thromboembolism.
Manufacturer:

Yabao Pharmaceutical Group Co., Ltd.

aspirin
Indication: 1. Analgesic and antipyretic; 2. Anti-inflammatory and anti-rheumatic; 3. Arthritis; 4. Anti-thrombotic; 5. Mucocutaneous lymph node syndrome (Kawasaki disease); 6. Prevention of gastrointestinal tumors; 7. Inhibition of platelet aggregation.
Manufacturer:

Wuyi Cihang Pharmaceutical Co., Ltd.

Isoamyl nitrite
Indication: No data yet
Manufacturer:

Lesheng Pharmaceutical Shijiazhuang Co., Ltd.

Isoamyl nitrite
Indication: No data yet
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.